Many Hospitals Lack All-Trans Retinoic Acid for Treating Leukemia

Many hospitals that care for patients with acute leukemia do not have all-trans retinoic acid (ATRA) in stock, according to a study published in the November issue of the Journal of the National Comprehensive Cancer Network. All-Trans Retinoic Acid for APL Noting that ATRA is the backbone of management for patients with acute promyelocytic leukemia … Continue reading Many Hospitals Lack All-Trans Retinoic Acid for Treating Leukemia